Ernesto Aycardi
Keine laufenden Positionen mehr
Profil
Ernesto Aycardi worked as a Senior Director of Worldwide Clinical Research at Merck & Co., Inc. from 1998 to 2009.
He then worked as the Director of Medical Research at Biogen Canada, Inc. from 2009 to 2013.
In 2013, he became a Senior Director at EMD Serono, Inc. for a year.
From 2014 to 2018, he worked as the Vice President and Head of Clinical Trial Operations at Teva Pharmaceutical Industries Ltd.
In 2018, he became the Chief Medical Officer at Xenon Pharmaceuticals, Inc. Dr. Aycardi earned a doctorate degree from Universidad Nacional de Colombia.
Ehemalige bekannte Positionen von Ernesto Aycardi
Unternehmen | Position | Ende |
---|---|---|
XENON PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | 23.04.2021 |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01.01.2018 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01.01.2014 |
Biogen Canada, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2013 |
MERCK & CO., INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 |
Ausbildung von Ernesto Aycardi
Universidad Nacional de Colombia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
XENON PHARMACEUTICALS INC. | Health Technology |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
MERCK & CO., INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Biogen Canada, Inc. |